Phase 1: Weeks 13 (Disc Repair Priority) BPC-157: 500mcg/day subQ TB-500: 2.5mg/week subQ GHK-Cu: 1mg/day subQ Focus: disc tissue repair, nerve decompression, anti-inflammation Activity: physical therapy, gentle mobility, no loading Phase 2: Weeks 48 (Add Recomp Layer) Continue Phase 1 stack Add CJC-1295 no DAC + Ipamorelin: 100mcg each, pre-bed This layer drives GH pulsatility for tissue remodeling and begins the body recomposition phase Activity: begin light lifting as cleared by PT Phase 3: Weeks 9+ (Maintenance and Fat Loss) TB-500: Drop to maintenance 1.25mg/week BPC-157: Can drop to 250mcg/day or 5 days/week CJC+Ipa: Continue pre-bed Optional add: Tesamorelin (12mg/day, 5 days/week) for visceral fat and GH optimization pairs well with CJC+Ipa Optional add: Retatrutide for more aggressive fat loss if that's a priority What to Expect: Recovery Timeline Weeks 12: Reduced acute nerve pain is often the first noticeable change
some clinicians dismiss it entirely
IV therapy involves delivering fluids directly into the bloodstream, bypassing the digestive system and allowing for rapid absorption of fluids and electrolytes
Maximum plasma concentration of cagrilintide was reached at 19 weeks, with half-life ranging between 159195 hours
Nasal spray peptides offer yet another option, particularly for peptides with neurological targets like selank, where intranasal delivery provides relatively direct access to the central nervous system
We recently provided the FDA with over 800 different studies that have been done on an array of the 19 peptides that were banned under the Biden administration
